← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 15, 2019Last known activity
Jun 20, 2022
Timeline
2010s
- Jan 1, 2012
ILiAD Biotechnologies— Founded
Drugs by trial phase (3 distinct, 3 trials)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT05461131Lead sponsorPhase 2Jun 20, 2022
- NCT05116241Lead sponsorPhase 2Nov 30, 2021
- NCT03942406Lead sponsorPhase 2Jun 15, 2019
Details
- Founded
- New York, NY, US Jan 1, 2012
- Last known activity
- Jun 20, 2022